Correlation Between Johnson Johnson and Galectin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Galectin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Galectin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Galectin Therapeutics, you can compare the effects of market volatilities on Johnson Johnson and Galectin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Galectin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Galectin Therapeutics.
Diversification Opportunities for Johnson Johnson and Galectin Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Johnson and Galectin is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Galectin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galectin Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Galectin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galectin Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Galectin Therapeutics go up and down completely randomly.
Pair Corralation between Johnson Johnson and Galectin Therapeutics
Considering the 90-day investment horizon Johnson Johnson is expected to generate 15.36 times less return on investment than Galectin Therapeutics. But when comparing it to its historical volatility, Johnson Johnson is 4.5 times less risky than Galectin Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Galectin Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 195.00 in Galectin Therapeutics on August 26, 2024 and sell it today you would earn a total of 83.00 from holding Galectin Therapeutics or generate 42.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Galectin Therapeutics
Performance |
| Timeline |
| Johnson Johnson |
| Galectin Therapeutics |
Johnson Johnson and Galectin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Galectin Therapeutics
The main advantage of trading using opposite Johnson Johnson and Galectin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Galectin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galectin Therapeutics will offset losses from the drop in Galectin Therapeutics' long position.| Johnson Johnson vs. Capricor Therapeutics | Johnson Johnson vs. Soleno Therapeutics | Johnson Johnson vs. Bio Path Holdings | Johnson Johnson vs. Moleculin Biotech |
| Galectin Therapeutics vs. Eliem Therapeutics | Galectin Therapeutics vs. HCW Biologics | Galectin Therapeutics vs. Scpharmaceuticals | Galectin Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |